SIGA Technologies, Inc. (SIGA)
| Market Cap | 229.20M -61.3% |
| Revenue (ttm) | 53.66M -70.1% |
| Net Income | -2.79M |
| EPS | -0.04 |
| Shares Out | 71.85M |
| PE Ratio | n/a |
| Forward PE | 63.80 |
| Dividend | $0.60 (18.81%) |
| Ex-Dividend Date | Apr 7, 2026 |
| Volume | 711,078 |
| Open | 3.130 |
| Previous Close | 3.100 |
| Day's Range | 3.110 - 3.265 |
| 52-Week Range | 2.830 - 8.545 |
| Beta | 0.96 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 5, 2026 |
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Financial Performance
In 2025, SIGA Technologies's revenue was $94.57 million, a decrease of -31.82% compared to the previous year's $138.72 million. Earnings were $23.28 million, a decrease of -60.69%.
Financial StatementsNews
SIGA Technologies Slides: Company presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on August 7, 2026.
SIGA Technologies Earnings Call Transcript: Q2 2026
Q2 2026 saw $38M in product revenues, driven by U.S. and international TPOXX deliveries, with net income of $12M and strong cash reserves. Progress continues on new U.S. contracts and international expansion, despite slower government procurement cycles.
SIGA Technologies Earnings release: Q2 2026
SIGA Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
SIGA Technologies Quarterly report: Q2 2026
SIGA Technologies has published its Q2 2026 quarterly earnings report on August 6, 2026.
SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference...
SIGA Technologies Transcript: AGM 2026
The meeting reviewed strong 2025 financials, highlighted strategic advances in TPOXX development, and approved all shareholder proposals, including board elections, auditor ratification, executive compensation, and a stock incentive plan amendment. Dividends and preparedness initiatives were emphasized.
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on May 8, 2026, providing details for shareholder voting and corporate governance matters.
SIGA Technologies Earnings Call Transcript: Q1 2026
Minimal Q1 deliveries led to a net loss, but a strong cash position enabled a special dividend. International expansion continues with a $13M Asia Pacific order and a new MENA partnership, while long-term outlook remains positive amid ongoing government engagement.
SIGA Technologies Earnings release: Q1 2026
SIGA Technologies released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
SIGA Technologies Quarterly report: Q1 2026
SIGA Technologies has published its Q1 2026 quarterly earnings report on May 7, 2026.
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 3...
SIGA Technologies Slides: Corporate presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on May 7, 2026.
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conferenc...
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
SIGA Technologies Proxy statement: Proxy filing
SIGA Technologies filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Siga Technologies declares 60c per share special cash dividend
Siga Technologies (SIGA) announced that its board of directors declared a special cash dividend of 60c per share on the company’s common stock. The amount of this dividend is consistent…
SIGA Declares Special Cash Dividend of $0.60 Per Share
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special ca...
Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.
The first severe case of the virus has been detected in New York.
SIGA Technologies Earnings Call Transcript: Q4 2025
2025 saw $88M in product revenue, $23M net income, and a $155M cash balance with no debt. U.S. and international demand for TPOXX remains strong, with new multi-year contracts and ongoing regulatory engagement in Europe. Capital allocation remains disciplined.
SIGA Technologies Annual report: Q4 2025
SIGA Technologies has published its Q4 2025 annual report on March 10, 2026.
SIGA Technologies Earnings release: Q4 2025
SIGA Technologies released its Q4 2025 earnings on March 10, 2026, summarizing the period's financial results.
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ...
SIGA Technologies Slides: Company presentation
SIGA Technologies has posted slides in relation to its latest quarterly earnings report, which was published on March 10, 2026.
SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conferenc...
SIGA Technologies Earnings Call Transcript: Q3 2025
Product revenue for the first nine months of 2025 rose to $86 million, with strong U.S. government and international sales. Cash remains robust at $172 million and no debt, supporting ongoing R&D and shareholder returns. Ongoing government engagement and pipeline progress position the company for future growth.